KCNN1 and anxiety disorder: In vivo infusion of SK activator 5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one (DCEBIO) in rats reduced recall of extinction memory, leading the authors to propose SK as a therapeutic target in anxiety disorders (Criado-Marrero et al., 2014).